CHICAGO, Sept. 11, 2014 /PRNewswire/ -- The Female Health Company (NASDAQ - CM: FHCO), which manufactures the world's leading female condom, today announced the increased access and use of FC2 Female Condom in Kenya.
The Female Health Company reports that it shipped 1.4 million FC2 Female Condoms to Kenya in the fourth quarter of FY2014 through the UNFPA (United Nations Population Fund), reflecting the success of in-country programming efforts. Working with the Muthaa Community Development Foundation (MCDF), more than 500 staff members at health facilities, NGOs, CBOs, student and government offices have been trained in the role, benefits and utilization of the FC2 Female Condom since the beginning of the year. The program involved the development and adaptation of education and information materials tailored specifically for the nation of Kenya.
"MCDF targets training to 'at risk' populations, as well as student and labor organizations," noted Emily Karechio, Founder and President of the Muthaa Community Development Foundation. "Organizations that we have trained are entitled to be issued FC2 Female Condoms for distribution, increasing the access to FC2 for the women in Kenya. The Female Health Company has invested in training and programming in Kenya since 2012, resulting in continued increases in FC2 distribution. More than 3.9 million units have been distributed as a result of these activities, thereby empowering and protecting more women throughout the country. Next year we will develop a mobile phone software application and reporting tool to improve consolidated data collection on FC2 distribution."
With a population of 43 million, and an HIV/AIDS rate of 6.1% within the ages 15-49 years, Kenya is a critically important country in which to continue FC2 programming activities.
"We normally do not publicly comment on routine order fulfillment through our large customers like UNFPA and USAID," stated Karen King, President and Chief Executive Officer of The Female Health Company. "These key customers are continually placing orders for FC2 throughout the year. However, we are particularly pleased with our partnership in Kenya and the progress being made there to reach and empower women. As Global Female Condom Day approaches, we want to celebrate these achievements and other ongoing efforts to increase awareness and demand for FC2 around the world."
Global Female Condom Day is September 16, 2014. Activities are planned worldwide to highlight the importance of making female condoms available to women everywhere.
About The Female Health Company
The Female Health Company, based in Chicago, Illinois, manufactures and markets the FC2 Female Condom® (FC2). Since the Company began distributing FC2 in 2007, the product has been shipped to 144 countries. The Company owns certain worldwide rights to the FC2 Female Condom®, including patents that have been issued in a number of countries around the world. The patents cover key aspects of FC2, including its overall design and manufacturing process. The FC2 Female Condom® is the only currently available female-controlled product approved by FDA that offers dual protection against sexually transmitted infections, including HIV/AIDS, and unintended pregnancy. The World Health Organization (WHO) has cleared FC2 for purchase by U.N. agencies.
Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995:
The statements in this release which are not historical facts are forward-looking statements based upon the Company's current plans and strategies, and reflect the Company's current assessment of the risks and uncertainties related to its business, including such things as product demand and market acceptance; the economic and business environment and the impact of government pressures; currency risks; capacity; efficiency and supply constraints; and other risks detailed in the Company's press releases, shareholder communications and Securities and Exchange Commission filings. Actual events affecting the Company and the impact of such events on the Company's operations may vary from those currently anticipated.
For more information about the Female Health Company visit the Company's website at http://www.femalehealth.com and http://www.femalecondom.org. If you would like to be added to the Company's e-mail alert list, please send an e-mail to FHCInvestor@femalehealthcompany.com.
SOURCE The Female Health Company
Press Release Kari Sharp